Photobiomodulation Therapy for Brain Disorders

Dear Colleagues,

In recent years, photobiomodulation (PBM) therapy has emerged as a promising modality with the potential to revolutionize the field of brain injury management and neurorehabilitation. Brain injuries, whether caused by traumatic events or neurological disorders, impose significant physical, psychological, and socioeconomic burdens on affected individuals and their communities. Despite advances in conventional rehabilitation approaches, there remains a pressing need to explore alternative strategies that can augment recovery and maximize functional outcomes for brain injury patients. PBM therapy, utilizing low-level light stimulation, offers an innovative and noninvasive approach that holds immense therapeutic potential.

PBM therapy, also known as low-level laser therapy or biophotomodulation, involves the application of specific wavelengths of light to targeted areas of the body. These wavelengths penetrate tissues, triggering a cascade of intracellular events with potential neuroprotective, anti-inflammatory, and regenerative effects. While PBM therapy has garnered considerable attention in various fields, including dermatology, pain management, and ophthalmology, its application in brain injury research is a rapidly growing area of interest.

This Special Issue aims to provide a comprehensive overview of the current state of research in photobiomodulation therapy for brain injury, highlighting the leading advancements made in understanding its mechanisms of action, exploring its potential applications, and evaluating its efficacy in preclinical and clinical studies. By bringing together a collection of cutting-edge research articles and reviews, this Special Issue intends to foster a deeper understanding of PBM therapy and its transformative impact on brain injury treatment. We welcome researchers, scientists, and clinicians working in the field to submit their original work to this Special Issue and contribute to the advancement of knowledge regarding the therapeutic applications of photobiomodulation therapy for brain injuries.

Dr. Denis Bragin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• photobiomodulation therapy
• brain injury
• traumatic brain injury (TBI)
• neurorehabilitation
• low-level laser therapy
• biophotomodulation
• laser neurostimulation
• neuroprotection
• anti-inflammatory effects
• regenerative potential